LSM2 Antikörper (AA 1-95)
-
- Target Alle LSM2 Antikörper anzeigen
- LSM2 (LSM2 Homolog, U6 Small Nuclear RNA Associated (LSM2))
-
Bindungsspezifität
- AA 1-95
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LSM2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant LSM2.
- Sequenz
- MLFYSFFKSL VGKDVVVELK NDLSICGTLH SVDQYLNIKL TDISVTDPEK YPHMLSVKNC FIRGSVVRYV QLPADEVDTQ LLQDAARKEA LQQKQ
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- LSM2 (NP_067000, 1 a.a. ~ 95 a.a) partial recombinant protein with GST tag.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 50 % glycerol
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma." in: Journal of proteomics, Vol. 94, pp. 186-201, (2013) (PubMed).
: "
-
Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma." in: Journal of proteomics, Vol. 94, pp. 186-201, (2013) (PubMed).
-
- Target
- LSM2 (LSM2 Homolog, U6 Small Nuclear RNA Associated (LSM2))
- Andere Bezeichnung
- LSM2 (LSM2 Produkte)
- Hintergrund
-
Full Gene Name: LSM2 homolog, U6 small nuclear RNA associated (S. cerevisiae)
Synonyms: C6orf28,G7b,YBL026W,snRNP - Gen-ID
- 57819
- NCBI Accession
- NM_021177
- Pathways
- Ribonucleoprotein Complex Subunit Organization
-